EPIRUS Biopharmaceuticals
About EPIRUS
EPIRUS Biopharmaceuticals (Nasdaq: EPRS) is a biopharmaceutical company building a focused, sustainable and profitable biosimilar company by improving patient access to important, cost-effective medicines worldwide.
- Focus : Manufacturer
- Industry : Biotechnology
Product portfolio of EPIRUS
Similar companies
Here you will find EPIRUS Biopharmaceuticals
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
